These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 10091177

  • 1. Rachitic rosary in a well chelated thalassaemic patient with primary amenorrhea (patient report).
    Lauriola AL, Tangerini A, Lodi A, Gamberini MR, Testa MR, Orzincolo C, De Sanctis V, Vullo C.
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():979-80. PubMed ID: 10091177
    [No Abstract] [Full Text] [Related]

  • 2. Growth failure and bone lesions due to desferrioxamine in thalassaemic patients.
    Caruso-Nicoletti M, Di Bella D, Pizzarelli G, Leonardi C, Sciuto C, Coco M, Di Gregorio F.
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():957-60. PubMed ID: 10091171
    [No Abstract] [Full Text] [Related]

  • 3. Yersinia enterocolitica as a cause of intra-abdominal abscess: the role of iron.
    Pallister C, Rotstein OD.
    Can J Surg; 2001 Apr; 44(2):135-6. PubMed ID: 11308237
    [No Abstract] [Full Text] [Related]

  • 4. [The mechanism of cataract formation in persons with beta-thalassemia].
    Popescu C, Siganos D, Zanakis E, Padakis A.
    Oftalmologia; 1998 Apr; 45(4):10-3. PubMed ID: 10418622
    [Abstract] [Full Text] [Related]

  • 5. Desferrioxamine-induced long bone changes in thalassaemic patients - radiographic features, prevalence and relations with growth.
    Chan YL, Li CK, Pang LM, Chik KW.
    Clin Radiol; 2000 Aug; 55(8):610-4. PubMed ID: 10964732
    [Abstract] [Full Text] [Related]

  • 6. Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.
    Vaskaridou E, Konstantopoulos K, Kyriakou D, Loukopoulos D.
    Haematologica; 1993 Aug; 78(3):183-4. PubMed ID: 8375749
    [Abstract] [Full Text] [Related]

  • 7. Site of subcutaneous desferrioxamine injection is the initial site of post-transfusion urticaria in multi-transfused beta-thalassaemia major patients.
    Daar S, Ghosh K, Nirmala V.
    Clin Lab Haematol; 2000 Feb; 22(1):55-6. PubMed ID: 10819612
    [No Abstract] [Full Text] [Related]

  • 8. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D.
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [Abstract] [Full Text] [Related]

  • 9. High incidence of osteoporosis in thalassaemia major.
    Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B.
    J Pediatr Endocrinol Metab; 1998 May; 11 Suppl 3():975-7. PubMed ID: 10091176
    [No Abstract] [Full Text] [Related]

  • 10. Current trends in management of the beta thalassemias.
    Shah D, Choudhury P, Dubey AP.
    Indian Pediatr; 1999 Dec; 36(12):1229-42. PubMed ID: 10745364
    [No Abstract] [Full Text] [Related]

  • 11. An endocrinologist's commentary.
    Stanhope R.
    J Pediatr Endocrinol Metab; 1998 Dec; 11 Suppl 3():1001-2. PubMed ID: 10091185
    [No Abstract] [Full Text] [Related]

  • 12. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A, Italia S, Campisi S.
    J Pediatr Endocrinol Metab; 1998 Dec; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J, Mitilineou E, Diamanti-Kandaraki E, Meletis J, Karagiorga M.
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [Abstract] [Full Text] [Related]

  • 14. Common queries in thalassemia care.
    Panigrahi I, Marwaha RK.
    Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
    Karamifar H, Shahriari M, Sadjadian N.
    East Mediterr Health J; 2003 Jun; 9(1-2):55-60. PubMed ID: 15562733
    [Abstract] [Full Text] [Related]

  • 16. Deferoxamine-induced dysplasia of the knee: sonographic features and diagnostic performance compared with magnetic resonance imaging.
    Chan YL, Chu CW, Chik KW, Pang LM, Shing MK, Li CK.
    J Ultrasound Med; 2001 Jul; 20(7):723-8. PubMed ID: 11444730
    [Abstract] [Full Text] [Related]

  • 17. Case report 744. Deferoxamine-induced skeletal dysplasia.
    Borenstein ZC, Hyman CB, Rimoin DL, Chapman CL, Lachman R.
    Skeletal Radiol; 1992 Jul; 21(8):534-7. PubMed ID: 1465648
    [No Abstract] [Full Text] [Related]

  • 18. Beta-thalassemia and pulmonary function.
    Piatti G, Allegra L, Ambrosetti U, Cappellini MD, Turati F, Fiorelli G.
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [Abstract] [Full Text] [Related]

  • 19. Osteopenia in female beta-thalassemic patients.
    Pafumi C, Roccasalva L, Pernicone G, Spanò G, Palumbo MA, Gregorio FD, Caruso-Nicoletti M, Conversano M, Cianci A, Palumbo G.
    J Pediatr Endocrinol Metab; 1998 Sep; 11 Suppl 3():989-91. PubMed ID: 10091181
    [Abstract] [Full Text] [Related]

  • 20. Induction of ovulation in thalassemic patients.
    Pafumi C, Ciotta L, Pernicone G, Palumbo MA, Di Gregorio F, Caruso-Nicoletti M, Conversano M, Cianci A, Palumbo G.
    J Pediatr Endocrinol Metab; 1998 Sep; 11 Suppl 3():987-8. PubMed ID: 10091180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.